A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic ...

Trump gives the impression that Americans will shortly see steep decreases in what they pay for prescription drugs. But even ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amphastar ...

While India’s domestic pharma market continues to grow, it has slowed from 9–10% to around 7% now. Against this backdrop, ...

The global Generic Pharmaceuticals Market size is projected to be valued at USD 391.5 billion in 2023 and reach USD 682.9 ...

Oral antidiabetic drugs play an important role in the management of type 2 diabetes and were developed to regulate blood glucose levels in individuals who are resistant to the effects of insulin or ...

Drug prices in the United States are astronomical and climbing. Many analysts blame mergers and acquisitions among ...

The HHS said it has taken the first step toward implementing most-favored-nation pricing for prescription drugs.

Kaddis said insurers are locked in a cat-and-mouse game with drugmakers as the insurance sector invests in biosimilars and ...

Innovation must be matched with accessibility, affordability, and regulatory excellence in this digital age. At the heart of this transformation is Shaileshbhai Kaklotar, a trailblazer in ...

Global oncology drug spending is expected to hit $441B by 2029 despite patent expirations later in the decade. Read more here ...

On May 16, 2025, Grace Graham, deputy commissioner for policy, legislation and international affairs at the Food and Drug Administration (FDA), delivered a keynote address at the Food and Drug Law ...